Dr. Nirmal Jot Kaur, MD

Dr. Kaur practices at Cardio Metabolic Institute in Somerset, New Jersey.

Dr. Kaur's NPI, 1114157302, was assigned on July 22, 2009. Dr. Kaur graduated from Madras Medical College in 2004. Dr. Kaur holds New York license 322067.

Dr. Kaur's primary practice is Cardio Metabolic Institute, at 51 Veronica Ave, Somerset, NJ 08873 in Somerset County. The practice phone is (732) 846-7000.

Dr. Kaur's primary practice is Cardio Metabolic Institute in Somerset, New Jersey. Dr. Kaur is also affiliated with Robert Wood Johnson University Hospital. The medical group on file is Cardio Metabolic Institute. Dmand AI also links Dr. Kaur to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaur practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kaur's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Kaur's licenses on file in 2 states: New York and Oklahoma.

Dmand AI lists angioplasty, cardiac catheterization, leg revascularization and pacemaker replacement among the conditions Dr. Kaur treats.

CMS data shows 1,240 Medicare services from Dr. Kaur across 12 procedure codes in 2024, for 310 Medicare patients. Medicare paid $72,208 for them.

CMS counts 310 Medicare patients who saw Dr. Kaur in 2024. The largest group is 75 to 84, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaur's median patient age at 62, with 53% women.

In 2024, Dr. Kaur wrote 1,095 Medicare Part D claims for 304 patients. 85% of them were for generic drugs. CMS names the drug for 987 of them, across 22 drugs with 11 or more claims each, at $114,787 in total drug cost. In 2023, CMS named 4,459 claims across 39 drugs.

Dr. Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kaur as offering telehealth. CMS counts 12 procedures of coronary angioplasty and stenting by Dr. Kaur, more than 33% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Kaur, published from 2015 to 2019. 2015 was the busiest year, with 2. The most frequent topics are Takotsubo Cardiomyopathy. Dr. Kaur has published most often in Am J Emerg Med. Dr. Kaur's most frequent co-authors are Vinod K. Chaubey, MD, Paramarajan Piranavan, MD and Fady Marmoush, MD.

CMS Open Payments shows 316 general payments to Dr. Kaur from 37 drug and device companies from 2016 to 2025. Grants make up the largest share, 76% of the total. Boston Scientific Corporation paid the most, $25,538.

Dr. Kaur graduated from Madras Medical College in 2004.

Dr. Kaur is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.